Results 101 to 110 of about 21,016 (175)

Daptomycin

open access: yes, 2018
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections including complicated skin and skin structure infections, right-sided infective endocarditis, bacteraemia, meningitis, sepsis and urinary tract infections ...
Heidary, M.   +5 more
core  

Genetic Basis for Daptomycin Resistance in Enterococci

open access: yes, 2011
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection is an important public health concern. Little is known about the genetic mechanisms by which enterococci adapt to strong selective pressures, including the
Jared Silverman   +4 more
core   +1 more source

Daptomycin-Induced Pulmonary Toxicity: A Case Series.

open access: yes, 2023
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin.
Natarajan, Sarasija   +3 more
core   +1 more source

Comparative Activity of Daptomycin and Teicoplanin against Enterococci Isolated from Blood and Urine

open access: yesCanadian Journal of Infectious Diseases, 1992
The authors compared the activity of daptomycin with that of ampicillin, penicillin, teicoplanin and vancomycin against 304 strains of Enterococcus species isolated from blood and urine.
Kevin R Forward   +3 more
doaj   +1 more source

Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone

open access: yes, 2009
We examined the cerebrospinal fluid penetration of daptomycin after the addition of dexamethasone and its bactericidal efficacy with and without ceftriaxone in an experimental rabbit model of pneumococcal meningitis.
Cottagnoud, M   +7 more
core   +1 more source

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol

open access: yes, 2014
Paul Zarogoulidis,1 Ioannis Kioumis,1 Sofia Lampaki,1 John Organtzis,1 Konstantinos Porpodis,1 Dionysios Spyratos,1 Georgia Pitsiou,1 Dimitris Petridis,2 Athanasia Pataka,1 Haidong Huang,3 Qiang Li,3 Lonny Yarmus,4 Wolfgang Hohenforst-Schmidt,5 Nikolaos ...
Spyratos D   +14 more
core  

Pre-clinical experience with daptomycin.

open access: yes, 2008
Daptomycin is a broad-spectrum, bactericidal agent active against Gram-positive bacteria, acting largely and unusually through membrane depolarization.
Hawkey, Peter
core   +1 more source

Genetic Basis for Daptomycin Resistance in Enterococci

open access: yes, 2018
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection is an important public health concern. Little is known about the genetic mechanisms by which enterococci adapt to strong selective pressures, including the
Hardy, C.   +4 more
core   +1 more source

Native valve endocarditis caused by corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

open access: yes, 2012
We describe a patient who developed Corynebacterium striatum native valve endocarditis after receiving two 6-week courses of daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Diaz, Lorena   +8 more
core   +1 more source

Effects of Cholesterol and Solution pH on Daptomycin-bilayer Interactions. [PDF]

open access: yesJ Membr Biol
Pennock SR   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy